Monsenso A/S (CPH:MONSO)

Market Cap	9.77M -61.4%
Revenue (ttm)	10.80M +0.6%
Net Income	-6.61M
EPS	-0.11
Shares Out	74.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	98,666
Average Volume	14,289
Open	0.1310
Previous Close	0.1310
Day's Range	0.1310 - 0.1320
52-Week Range	0.1000 - 0.4000
Beta	1.18
RSI	52.58
Earnings Date	Mar 5, 2026

About Monsenso

Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution, a software as a medical device for mental health professionals application that has data collection, direct messaging, visualization and feedback, psy...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2013
• Employees: 12
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: MONSO

Financial Performance

In 2024, Monsenso's revenue was 11.17 million, an increase of 16.01% compared to the previous year's 9.62 million. Losses were -6.00 million, 12.0% more than in 2023.